According to the novel WHO 2022 classification, two B-PLL cases might be classified as prolymphocytic transformation of CLL, and one case is CD5-negative, and would now be included in the group of splenic B-cell leukemia with prominent nucleoli (SBLP) [1]. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.